Most women should start getting mammograms at age 40 and continue every two years through age 74. That’s the current recommendation from the U.S. Preventive Services Task Force, updated in April 2024 to lower the starting age from 50 to 40. If you have certain risk factors, you may need to start even earlier or screen more frequently.
Standard Screening Ages and Frequency
The two major organizations that issue screening guidelines differ slightly on timing, which can cause confusion. Here’s how they break down:
The USPSTF recommends a straightforward schedule: a mammogram every two years from age 40 through 74. This applies to women at average risk, meaning no known genetic mutations, no prior breast cancer, and no history of chest radiation.
The American Cancer Society takes a more layered approach. Women ages 40 to 44 can choose to start annual screening if they want to. From 45 to 54, the ACS recommends mammograms every year. At 55 and older, women can switch to every two years or continue yearly. Both schedules are considered reasonable, so the choice comes down to your personal preferences and risk profile.
The practical takeaway: if you’re 40 or older and haven’t had a mammogram yet, it’s time to schedule one. If you’re between 40 and 44 and unsure whether to start, your family history and personal comfort with screening can help guide that decision.
Who Should Start Before Age 40
Some women need screening well before the standard starting age. If you carry a BRCA1 or BRCA2 gene mutation, or have another known genetic mutation linked to breast cancer (such as TP53, PALB2, or ATM), guidelines recommend annual mammograms starting at age 30. Women in this category are also typically advised to get a breast MRI every year in addition to mammography, starting as early as 25 to 30.
You don’t need a confirmed genetic mutation to qualify as high risk. Having multiple first-degree relatives (a mother, sister, or daughter) with breast cancer puts you at elevated risk even without genetic testing. A calculated lifetime risk of 20% or higher, based on your family history and other factors, is the threshold where enhanced screening kicks in.
Women who received radiation to the chest before age 30, often as treatment for another cancer like lymphoma, face an increased breast cancer risk that typically becomes significant about eight years after exposure. If that applies to you, annual screening mammography and MRI are recommended starting at age 25 to 30.
There’s also a common informal practice among women with a family history: starting mammograms 10 years before the age their relative was diagnosed. If your mother was diagnosed at 42, you’d begin at 32. Research from the Breast Cancer Surveillance Consortium found that about 65% of women who started screening before 40 were following this pattern. It’s not an official guideline, but it reflects a real conversation worth having with your doctor if breast cancer runs in your family.
When to Get a Mammogram Right Away
Screening mammograms are routine, scheduled exams for women without symptoms. A diagnostic mammogram is different. It’s ordered when something specific needs investigating, and your age doesn’t matter. If you notice a breast lump, nipple thickening, bloody or clear nipple discharge, unexplained pain, or a change in breast size or shape, a diagnostic mammogram may be needed regardless of whether you’re 30 or 70.
The distinction matters for more than medical reasons. Screening and diagnostic mammograms can be billed differently by insurance, and the imaging itself is more targeted during a diagnostic exam, with extra views focused on the area of concern.
What Dense Breast Tissue Means for Timing
As of September 2024, every mammography facility in the U.S. is required to tell you whether your breast tissue is dense. This is part of an FDA rule that took full effect that month. Your results letter will now include one of four density categories, ranging from “almost entirely fatty” to “extremely dense.”
Dense breast tissue matters for two reasons. First, it makes cancers harder to spot on a standard mammogram because both dense tissue and tumors appear white on the image. Second, dense tissue itself is an independent risk factor for breast cancer. If your results say your tissue is “heterogeneously dense” or “extremely dense,” the notification will mention that additional imaging tests may help find cancers that mammography alone could miss. Breast MRI or ultrasound are common supplemental options.
About half of women have dense breast tissue, so this isn’t rare. If you’ve been told your breasts are dense, it doesn’t mean you need to panic, but it does mean screening with mammography alone may not be enough.
3D vs. 2D Mammograms
If you’re offered a choice between a standard 2D mammogram and a 3D mammogram (called digital breast tomosynthesis), the 3D version has measurable advantages. In community-based screening, 3D mammography detected 29% more cancers overall and 44% more invasive cancers compared to 2D. At the same time, the recall rate, where you’re called back for additional imaging after an initial screening, dropped by 16%.
That means 3D mammography finds more real cancers while generating fewer false alarms. Most screening centers now offer 3D mammography as the default, and insurance coverage for it has become widespread. If you have the option, it’s the better choice, particularly if you have dense breast tissue.
When to Stop Screening
The USPSTF recommendation covers women through age 74. Beyond that, the evidence becomes less clear. The task force hasn’t issued a recommendation for or against screening after 74, largely because there aren’t enough studies in that age group to draw firm conclusions.
In practice, the decision to continue screening past 74 depends on your overall health and life expectancy. Mammography is most beneficial when you’re likely to live long enough for early detection to make a difference in outcomes. For women in their late 70s and beyond who are in good health, continuing screening is reasonable. For those with serious health conditions that limit life expectancy, the potential harms of screening, including false positives, unnecessary biopsies, and anxiety, may outweigh the benefits.
Do Men Need Mammograms?
Male breast cancer is rare, and routine screening mammography is not recommended for men, even those with BRCA1 or BRCA2 mutations. However, men who carry these mutations do have an elevated lifetime risk, and guidelines suggest regular clinical breast exams starting at age 35 along with monthly self-exams. For men with BRCA mutations who also have enlarged breast tissue, a baseline mammogram followed by annual screening may be considered. Any man who notices a palpable lump or other breast change should get a diagnostic mammogram regardless of age or risk category.